Passage BIO (PASG) Change in Acquisitions & Divestments (2021 - 2025)
Passage BIO (PASG) posted quarterly Change in Acquisitions & Divestments of $39.0 million for Q1 2025, little changed year-over-year from $39.1 million in Q1 2024, and up 33.41% quarter-over-quarter from $29.3 million in Q4 2024.
Passage BIO (PASG) Change in Acquisitions & Divestments (2021 - 2025) Analysis & Trends
Passage BIO's Change in Acquisitions & Divestments history runs 5 years deep, the most recent figure standing at $39.0 million for Q1 2025.
- In Q1 2025, Change in Acquisitions & Divestments changed 0.04% year-over-year to $39.0 million; the TTM figure through Dec 2025 stood at $39.0 million (down 72.72% YoY), while the FY2025 annual figure was $39.0 million, down 72.72% from the prior year.
- Change in Acquisitions & Divestments for Q1 2025 stood at $39.0 million, up from $29.3 million in the prior quarter.
- The five-year high for Change in Acquisitions & Divestments was $72.6 million in Q1 2023, with the low at $29.3 million in Q4 2024.
- The 5-year median for Change in Acquisitions & Divestments is $38.6 million (2022), against an average of $44.0 million.
- The sharpest annual moves came in 2022 and 2024: Change in Acquisitions & Divestments soared 44.46% in 2022, then tumbled 46.23% in 2024.
- Passage BIO's Change in Acquisitions & Divestments stood at $36.4 million in 2021, then increased by 6.17% to $38.6 million in 2022, then slipped by 8.39% to $35.4 million in 2023, then declined by 17.33% to $29.3 million in 2024, then soared by 33.41% to $39.0 million in 2025.
- Business Quant data shows PASG's Change in Acquisitions & Divestments at $39.0 million in Q1 2025, $29.3 million in Q4 2024, and $36.8 million in Q3 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Passage BIO | 13.99 Mn | 13.99 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 39.05 Mn |
| Mar 31, 2025 | 39.05 Mn |
| Dec 31, 2024 | 29.27 Mn |
| Dec 31, 2024 | 29.27 Mn |
| Sep 30, 2024 | 36.76 Mn |
| Sep 30, 2024 | 36.76 Mn |
| Jun 30, 2024 | 38.06 Mn |
| Jun 30, 2024 | 38.06 Mn |
| Mar 31, 2024 | 39.06 Mn |
| Mar 31, 2024 | 39.06 Mn |
| Dec 31, 2023 | 35.41 Mn |
| Dec 31, 2023 | 35.41 Mn |
| Sep 30, 2023 | 50.57 Mn |
| Sep 30, 2023 | 50.57 Mn |
| Jun 30, 2023 | 36.20 Mn |
| Jun 30, 2023 | 36.20 Mn |
| Mar 31, 2023 | 72.64 Mn |
| Mar 31, 2023 | 72.64 Mn |
| Dec 31, 2022 | 38.65 Mn |
| Dec 31, 2022 | 38.65 Mn |